At Bar-B-Clean of Kansas City, our mission is to promote a healthy, family-oriented lifestyle to our clients while pioneering and leading the barbecue cleaning industry.Bar-B-Clean has developed a unique steam cleaning system that ensures the best results possible for our customers. If your grill hasn't been cleaned in over a year, there’s a good chance it is full of nasty remnants left behind by rodents and insects, contains carcinogenic leftover food particles, germs, mold, and who knows what else. Let our team take this dirty but important chore off your hands. In addition, our trained professionals can replace worn parts as needed, and if your grill is beyond repair, we can order you a new one and install that too.Bar-B-Clean of Kansas City isn’t solely about grill cleaning and maintenance either; it’s about preserving the essence of togetherness, laughter, and the delicious aroma of a well-grilled meal.

Fueling healthcare innovation through passion, experience, and revenue generation.Delivering long term, strategic, collaborative, and successful business relationships built on mutual trust and respect by connecting the best scientific minds (customers) with novel product and solution providers (clients) to help tackle today’s biggest health challenges.

Harnessing Computational Pathology and AI to Expedite the BioPharma Pipeline and Portfolio Success.

Congenica is a UK-based digital health company enabling the rapid analysis and interpretation of genomic data, empowering researchers to provide life-changing answers that will improve well being and disease management.Born out of pioneering research from the Wellcome Sanger Institute and the NHS, Congenica has a global footprint supporting leading international laboratories, academic medical centers and biopharmaceutical companies and is the exclusive Clinical Decision Support partner for the NHS Genomic Medicine Service.

Responsible for collaborating with pharmaceutical and biotech companies to enable precision medicine through advanced diagnostics. Guided by the physicians and scientists at the Mayo Clinic, we provide laboratory testing, test development, and sponsored testing services along with analytical validation support, biospecimen access, biobanking services, and other lab services for companion diagnostics and personalized medicine.

Responsible for leading all commercial and marketing activities for Orbis Biosciences. Developing relationships with pharmaceutical companies to optimize their product portfolios by integrating Orbis' novel microparticulate drug formulation technology. Utilizing our Precision Particle Fabrication® technology, Orbis provides innovative non-adherence solutions for taste-masking and extended release of oral and injectable pharmaceutical products.

Responsible for the US launch and commercialization of ANGLE's lead RUO product, Parsortix, a cell separation system used for delivering liquid biopsy solutions and rare cells for precision medicine. ANGLE plc is a commercially driven specialty medical diagnostics company with pioneering products in cancer diagnostics and fetal health.

Responsible for managing the West Region sales team and helping drive the increased utilization of circulating tumor cells (CTCs) and other rare cell technologies into the biotechnology and pharmaceutical sector as well as key academic research centers, NCI institutions, oncology clinics, hospitals, and cancer research centers across Western US and Canada. Products include molecular diagnostic instruments, reagents, and custom oncology lab services.* Active member of senior leadership involved in gaining product access and reimbursement, sales training, compensation planning, launching sales force automation, creating digital marketing strategy, and long term business planning.* In 2014 helped lead launch of Sylvant (siltuximab), a monoclonal antibody, used to treat multicentric Castleman's disease, an ultra rare lympho proliferative disease. This was the first orphan drug that was fully developed and brought to market by J&J.* Achieved business plans consecutively from 2011 through 2015 despite extremely challenging reimbursement coverage and lack of clinical guidelines for Circulating Tumor Cells (CTCs) by coaching courage, commitment, and collaboration to the team and being results and performance driven.* Helped launch next generation sequencing panel (NGS) panel allowing researchers to interrogate single cancer cells from a tube of blood versus invasive and difficult to obtain tumor biopsies.

* Responsible for selling molecular diagnostics equipment, reagents, and custom oncology lab services to Pharmaceutical and Biotech companies.* Introduced CellSearch, the first and only FDA approved technology for capturing, enumerating, and analyzing Circulating Tumor Cells (CTCs) to translational medicine directors and biomarker discovery teams at pharma and biotech companies.* Created market acceptance of CTCs as surrogate endpoint in pre-clinical research through large phase 3 clinical trials and securing technology as a real time liquid biopsy.* 2010 Finished at 102% to quota* 2010 Named interim CRS sales manager* 2010 Business Manager of the Year* 2010 Ambassador Club Trip Winner – Napa Valley, CA * Achieved 122% of quota in 2009* 2009 Business Manager of the Year* 2009 Ambassador Club Winner - Sunny Isles Florida * Achieved 101% of quota in 2008* 2008 Area Specialist of the Year* 2008 Ambassador Club Winner - Costa Rica

* Launched, GeneSearch®, the first FDA approved molecular (RT-PCR) test for intra-operative breast sentinel lymph node analysis. Product awarded Time Magazine’s Top 10 Medical Breakthroughs of 2007. * Field marketing role that assisted in pre-launch activities like prepping for and attending FDA panel meeting.* Collaborated with Ethicon Endo Surgery and Ortho-Clinical Diagnostics teams to create national sales funnel.* Cold called national thought leaders in surgical oncology, gained their support, and built clinical speaker program. * Presented clinical data at Grand Rounds and Tumor Boards to molecular pathologists, surgical oncologists, and administrators at top 25 NCI Cancer Centers in the country.* 2007 Awarded two Encore Achievement Awards by management and peers for product pre-launch leadership

* Sold diagnostic chemistry and blood bank analyzers to hospital laboratories.* Grew territory $545,000 in first six months in the field* 109% of quota in 2004.* #1 Rep in instrument placements in 2005* 130% of quota in 2005* Lexus GS300 Car Winner 2005* 2005 Ambassador Club Winner - Bahamas * 2006 Best of Best Trip - Spain* Managed largest sales volume territory in company with annual sales over $10 million

* Sold Surgical mesh, sutures, and surgical adhesives to operating room* Division of the Year Member - 2000* $30,000 Sales Club Winner - Ethicon Watch Club* Stock Award winner in 2001* Attained 128% quota in 2000* Attained 131% quota in 2001* $75,000 Sales Club Winner - Ethicon Ring Club* Promoted to CV 25 Specialist to co-sell J&J Cardiovations products in 2002* Finished #2 in country in Endo Radial Artery Kits in 2003* Top 10% of sales force in 3/4 product groups in 2003* Achieved 125% of quota in 2002* Achieved 132% of quota in 2003* Stock award winner in 2002

* Sold specialty sterile wound dressings for chronic skin ulcerations to hospitals and wound care clinics.* Ring Club Winner - $100,000 Cumulative Commissions - 1998* Promoted to Field Sales Trainer - April 1999* 1999 Glamour Prize Winner - Rome

* Responsible for distribution sales of medical supplies to long term care centers.* Developed new expansion territory in Illinois* Opened 26 new accounts, and gained $80,000 in first 4 months in territory.* Sales person of the month - August 1995* Achieved sales forecast in 1995 and 1996